Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Atrial fibrillation

Kaushik Guha
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.19-1-90
Clin Med January 2019
Kaushik Guha
Queen Alexandra Hospital, Portsmouth, UK
Roles: Consultant cardiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – Clayton and colleagues should be congratulated on focussing on an important cohort of patients within intensive care. The authors report a retrospective observational analysis in a cohort of patients who develop novel atrial fibrillation/atrial flutter within a generalised intensive care unit setting.1

However beyond the salient discussion and conclusion the data highlights further points of note.

Firstly within the reported demographics there is no description of contemporary left ventricular function as measured on echocardiography. The group of patients who developed new onset atrial arrhythmias had an increased incidence of atherosclerotic disease, hypertension and diabetes all of which increase the chance of incident left ventricular systolic dysfunction. Atrial fibrillation with uncontrolled ventricular rates may also in itself induce a tachycardia-associated cardiomyopathy. Finally, the patient admitted to intensive care is critically unwell with other pathology, eg sepsis, which may also induce myocardial dysfunction.2

Hence the development of atrial fibrillation within such patients should be an opportunity to consider a detailed cardiology review, consideration of cardiac monitoring, rationalisation of inotropes and potentially serial detailed assessments of left ventricular function using echocardiography.

Secondly the presence of atrial arrhythmias should be communicated following successful discharge from the intensive care unit to the ward. Beyond using short-term anticoagulant measures, prior to discharge the patient should have formal evaluation of their thromboembolic risk and bleeding risks documented. There should be consideration of the appropriateness of anticoagulation and correct method. This should also include the patient and family with full detailed anticoagulation counselling. It is imperative that such important clinical information follows the patient throughout the rest of their hospital stay, but following a complex lengthy admission it is not unusual to find that the ultimate discharge summary does not contain any mention of atrial arrhythmias nor the need to review anticoagulation.

  • © Royal College of Physicians 2019. All rights reserved.

References

  1. ↵
    1. Clayton B
    , Ball S, Read J, Waddy S. Risk of thromboembolism in patients developing critical illness associated atrial fibrillation. Clin Med 2018;18:282–7.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Ponikowski P
    , Voors AA, Anker SD, Bueno H, et al. 2016 European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the treatment of acute and chronic heart failure of the European Society of Cardiology. Eur Heart J 2016;37:2129–200.
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Atrial fibrillation
Kaushik Guha
Clinical Medicine Jan 2019, 19 (1) 90; DOI: 10.7861/clinmedicine.19-1-90

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Atrial fibrillation
Kaushik Guha
Clinical Medicine Jan 2019, 19 (1) 90; DOI: 10.7861/clinmedicine.19-1-90
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides
  • Response
  • Functional disorders and chronic pain
Show more Letters to the editor

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians